e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk factors for lung disease progression in children with cystic fibrosis
Marieke van Horck, Kim van de Kant, Bjorn Winkens, Geertjan Wesseling, Vincent Gulmans, Han Hendriks, Chris van der Grinten, Quirijn Jöbsis, Edward Dompeling
Source:
Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
Journal Issue:
June
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marieke van Horck, Kim van de Kant, Bjorn Winkens, Geertjan Wesseling, Vincent Gulmans, Han Hendriks, Chris van der Grinten, Quirijn Jöbsis, Edward Dompeling. Risk factors for lung disease progression in children with cystic fibrosis. Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
The impact of anti-IgE treatment on the airway microbiome in asthma.
Related content which might interest you:
Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood
Source: Virtual Congress 2020 – Respiratory diseases in children and adults
Year: 2020
Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002
Relations between the sinonasal development and the lung disease in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 103s
Year: 2005
Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
Elucidating progression of early cystic fibrosis lung disease
Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017
Year: 2017
Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002
Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016
Year: 2018
Questions of predicting and preventing the progression of pneumofibrosis in children with cystic fibrosis
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021
Predictive factors of lung function decline in adults with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 714s
Year: 2006
Comorbidities of advanced diseases in patients with cystic fibrosis
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020
Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014
Lung function in children with cystic fibrosis liver disease
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept